SecBot SecBot
8-K ·Filed Aug 28, 2026

PHGE

BiomX Inc.
NEUTRAL
Impact 4/10
Horizondays Processed2mo ago SEC0001213900-26-095146
Actionable Insight • Neutral

Monitor for the Certificate of Amendment filing (Item 5.03 8-K) and the first day of split-adjusted trading on September 9. The reverse split does not change fundamentals but may reduce liquidity and increase volatility in the near term. Watch for any subsequent capital raise announcements that often follow reverse splits at micro-cap companies.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$0.1371
T+0 close · Aug 28, 2026 · via day close
Latest settled
+13.06%
T+5 · $0.1550
Vs SPY
+13.20%
α at T+5
Next horizon
T+20
due 7w ago
  1. T+0 · Aug 31 $0.1371entry
  2. T+1 · 3mo ago +4.30%α +4.99% · $0.1430
  3. T+5 · 2mo ago +13.06%α +13.20% · $0.1550
  4. T+20 · due 7w ago Pending
  5. T+54 · todayOpen
  6. T+60 · in 7d Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BiomX Inc. announced a 1-for-10 reverse stock split, approved by stockholders on August 25, 2026, effective September 9, 2026. The split reduces outstanding shares from ~26.7M to ~2.7M and authorized shares from 750M to 150M. This is a routine capital structure adjustment to maintain NYSE American listing compliance, with no fundamental business change.

Key Facts

  • Reverse stock split ratio fixed at 1-for-10 by Board on August 28, 2026
  • Effective at 12:01 a.m. ET on September 9, 2026
  • Outstanding shares reduced from ~26.7M to ~2.7M
  • Authorized shares reduced from 750M to 150M
  • Stockholders approved at special meeting on August 25, 2026
  • No fractional shares issued; rounding up to next whole share
  • Proportionate adjustments to warrants, convertible instruments, and equity awards
  • New CUSIP number 09090D 608 assigned

Financial Impact

No financial impact; mechanical share consolidation with no change to proportional ownership

sharesOutstandingauthorizedShares

Risk Factors

  • Post-split price may not hold above NYSE American continued listing standards
  • Reduced share count could amplify price volatility
  • Potential for subsequent dilutive offering common after reverse split

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (PHGE), Batch item 10001213900-26-095146
Document: 0001213900-26-095146-index.html0001213900-26-095146
Document: 0001213900-26-095146.txt0001213900-26-095146
8-K Filing (PHGE), Batch item 40001213900-26-095146
Document: 0001213900-26-095146-index.html0001213900-26-095146
Document: 0001213900-26-095146.txt0001213900-26-095146

Track record

22 reports on PHGE

Performance horizon

8 of 12 bullish or bearish reports moved the stock their way by T+1. Best: +62.36% at T+20 after the Jun 16, 2026 report. 8 of 12 went positive at some point.

Filters
  1. Oct 7, 20265w ago 8-K Neutral 4/10 Entry $0.3092 to $0.2915 ▼ −5.72% −5.30% vs SPY
  2. Oct 7, 20265w ago DEF 14A Bearish 6/10 Entry $0.3092 to $0.2915 ▲ +5.72% +5.30% vs SPY
  3. Sep 1, 202610w ago 8-K Neutral 3/10 Entry $0.1425 to $0.1421 ▼ −0.28% −1.33% vs SPY
  4. Aug 28, 202611w ago 8-K Neutral 4/10 Viewing Entry $0.1371 to $0.1430 ▲ +4.30% +4.99% vs SPY
  5. Aug 5, 202614w ago Press Release Bearish 5/10 Entry $0.1800 to $0.1598 ▲ +11.22% +11.06% vs SPY
  6. Jul 28, 202615w ago 8-K Bearish 8/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
  7. Jul 28, 202615w ago Press Release Bearish 7/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
  8. Jul 27, 202616w ago 424B5 Bearish 7/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
  9. Jul 8, 202618w ago Press Release Neutral 4/10 Entry $0.2758 to $0.2800 ▲ +1.52% +0.68% vs SPY
  10. Jul 2, 202619w ago 8-K Bearish 6/10 Entry $0.3190 to $0.3020 ▲ +5.33% +6.20% vs SPY
Showing 10 of 22

US Market Status

Market Closed · Opens in 4h 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 28, 2026